… The clinical course of OM generally is predictable and is affected by the kinetics of anticancer
treatment. Early clinical signs of chemotherapy-induced OM appear within approximately 3 …

… site involved (oral or gastrointestinal) and the treatment received. … as a secondary effect of
anti-cancer treatment is an important … of complications are essential to increase therapeutic …

… In conclusion, mucositis is a common adverse effect of anticancer therapy and can contribute
negatively to patient outcomes. The optimal management of these patients is an ongoing …

… to mucositis, a painful side effect of antineoplastic treatments. About 40% of the patients …
19% of the latter will be hospitalized and will experience a delay in antineoplastic treatment …

… , in particular since the advent of oral anticancer agents (OAA) (ie, oral antineoplastic agents
… to their anticancer treatment. For 19.0% of them, the CAMs used included at least one plant. …

… for extensive use of small molecule kinase inhibitors as anticancer therapy 8,17 , and a
number of anticancer molecular targeted therapies have been approved for clinical use in cancer …

… are common and often dose-limiting side-effects. In patients with … and treatment of peripheral
neurotoxicity and specific aspects of central neurotoxicity due to antineoplastic therapy are …

… treatment requires drug exposure for prolonged periods [46]. Unfortunately, oral administration
of most anticancer drugs is … common anticancer drugs used for the treatment of oral cavity …

… A plethora of anti-cancer drugs and natural medicinal compounds have been devised
over the years, which can suppress tumor growth through diverse mechanisms. Some of the …

… The high risk of recurrence and bleeding as well as concomitant anticancer treatment make
… specific clinical trials are required to claim for the efficacy and safety of a particular treatment …